Journal
DRUG DISCOVERY TODAY
Volume 14, Issue 11-12, Pages 562-569Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2009.03.013
Keywords
-
Categories
Ask authors/readers for more resources
The benefit offered by virtual screening methods during the early drug discovery process is directly related to the predictivity of scoring functions that assess protein-ligand binding affinity. The scoring of protein-ligand complexes, however, is still a challenge: despite great efforts, a universal and accurate scoring method has not been developed up to now. Targeted scoring functions, in contrast, enhance virtual screening performance significantly. This review analyzes recent developments and future directions in the area of targeted scoring functions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available